A New Frontier in Parkinson’s Research: The PRISMS Study

✨🧠 Could treating inflammation early protect the brain from Parkinson's disease before symptoms ever start?✨🧠

Researchers at the Yale School of Medicine are launching the PRISMS study—a groundbreaking clinical trial investigating whether targeting early brain inflammation can slow or prevent Parkinson’s disease.

The study focuses on individuals with REM Sleep Behavior Disorder (RBD), a condition where people act out their dreams, now recognized as one of the earliest indicators of Parkinson's risk.

💡 By intervening early, researchers hope to protect brain cells and open new doors for disease-modifying therapies.

Learn more about this hopeful step forward in the Yale Daily News: